NCT07543601 Enhanced COPD Management in Suspected Lung Cancer Patients
| NCT ID | NCT07543601 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ditte Krag-Hansen |
| Condition | COPD (Chronic Obstructive Pulmonary Disease) |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2026-03-06 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2026-03-06 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Identifying and treating COPD in patients undergoing lung cancer evaluation is crucial. Early intervention could lead to better management of both diseases, improving health status, reducing healthcare costs, and potentially increasing survival rates. This study aims to assess the impact of early diagnosis and optimal treatment of COPD on clinical outcomes in patients under evaluation for lung cancer. The study will combine information through an open-label RCT at the Lung Cancer Investigation Unit at Lillebaelt Hospital Vejle. The findings could inform clinical practice by emphasizing the importance of integrated care approaches for patients with coexisting COPD and lung cancer, ultimately leading to better health outcomes.
Eligibility Criteria
Inclusion Criteria: * Undergoing diagnostic evaluation for suspected lung cancer * Spirometry showing obstructive airflow limitation (FEV₁/FVC \< 75 % or FEV₁ \< 80 %, and no reversibility) at the first outpatient visit at the lung cancer evaluation Exclusion Criteria: * Presence of significant comorbidities that may interfere with diagnostic procedures or spirometry * Pregnant or breastfeeding women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07543601 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD (Chronic Obstructive Pulmonary Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07543601 currently recruiting?
Yes, NCT07543601 is actively recruiting participants. Contact the research team at ditte.krag-hansen@rsyd.dk for enrollment information.
Where is the NCT07543601 trial being conducted?
This trial is being conducted at Vejle, Denmark.
Who is sponsoring the NCT07543601 clinical trial?
NCT07543601 is sponsored by Ditte Krag-Hansen. The trial plans to enroll 280 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.